Short-course antiretroviral therapy in primary HIV infection

Sarah Fidler, Kholoud Porter, Fiona Ewings, John Frater, Gita Ramjee, David Cooper, Helen Rees, Martin Fisher, Mauro Schechter, Pontiano Kaleebu, Giuseppe Tambussi, Sabine Kinloch, Jose M Miro, Anthony Kelleher, Myra McClure, Steve Kaye, Michelle Gabriel, Rodney Phillips, Jonathan Weber, Abdel BabikerSPARTAC Trial Investigators

Research output: Contribution to journalArticlepeer-review

Abstract

Short-course antiretroviral therapy (ART) in primary human immunodeficiency virus (HIV) infection may delay disease progression but has not been adequately evaluated.
Original languageEnglish
Pages (from-to)207-17
Number of pages11
JournalNew England Journal of Medicine
Volume368
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Dive into the research topics of 'Short-course antiretroviral therapy in primary HIV infection'. Together they form a unique fingerprint.

Cite this